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Epidermal cell proliferation is required for re-epithe-
lialization during wound repair. Re-epithe1ialization 
of partial thickness excisional wounds in pigs is COlU-
plete by 6 days after injury. The presence of insulin-
like growth factor-I (IGF-I) and heparin-binding mol-
ecules that are mitogenic for keratinocytes was 
examined in wound fluid obtained daily from these 
wounds. Two significant heparin-binding growth 
factor activities for Balb/MK keratinocytes were de-
tected, a major one that was eluted frolu a heparin 
affinity column with 1.1 M NaCI and a minor one with 
0.5 M NaCl. These activities appeared 1 day after 
injury, were maximal by 2-3 days later, and disap-
peared by 6 days after injury. The molecule eluting 
T he hea ling of a wound is characterized by fibroplasia, angiogen es i ~, and ~e-e~itheliaJizatiol1 . . l.nhercnt in thIs process IS the 111IgratIon and proliferatio n of cells such as fibrobla sts, capillal)' endothelial cells, and epith elial cell s. Growth fi\ctors produced by platelets, 
Illonocytes/ma crophages, and by other cells in the damaged tissue 
appear to m ediate these migratory and proliferative even ts . R.e-
epithelialization is an essentia l step in the wound healing process. 
Keratin ocytes, which constitute the main cell type in the e pidermis, 
migrate in to the wound and proliferate soon afte r injury . 
Control of keratinocyte growth via the epid erma l growth filctor 
(EGF) and th e insulin-like growth fa c tor-l (lG F-I) receptor path-
ways may be c ritical to the normal structure and fun ction of the 
epidermis. EGF promotes skin maturation and produce increased 
thickness of n ormal appeari ng epidermis (Cohen, 1962; Cohen and 
Elliotte, 1963). A mixture of in sui iIi or lGF-1 and EGF or fibroblast 
growth factor (FGF) is required for tbe optimal growth of kerati-
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with 1.1 M NaCI was heparin-binding EGF-like (HB-
EGF). The levels of IGF-I in wound fluid were 45-90 
ng/ml during the first 3 days following injury, de-
creased thereafter, and were not detectable 6 days 
after injury. IGF-I at 100 ng/ml, increased HB-EGF 
mitogenic activity for Balb/MK keratinocytes by 40-
50-fold. We conclude that the synergism between 
IGF-I and HB-EGF and their relative concentrations 
at the various days after injury may be important 
variables for regulating re-epithelialization during 
wound repair. Key JlJOIrds: epidem,al g.'o,vtllfactodillsIlU1I1 
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nocytes in serum-free medium (Maciag el fI/ , 198 '1; O'Keefe 1'1 a/ 
1988; I~heinwald and G reen, 1977; Shipley el fI/ , '1989; Tsao et fI/, 
1982). Both EGF and IGF-I receptors are detected in normal hum <1.11 
epidermis, predominantly within the b 'lsal prol ife ra tive cell com-
partment (G I'een and Couchman , 1985; Krane c( ai, 1991). In 
addition , h yperplastic epidermis in psoriasis displays increased EGF 
receptors (Nanney d fI/, 1986) and JGF-r receptors (Krane e( fI/, 
1992) , indicating that potential in teractions between the lGF-I and 
EGF receptor pathways may be re levan t to keratin ocyte g rowth 
regulation ;/1 /I ;va. 
R ecently, we described a novel member of the epidermal growth 
factor family tha t is produced by monocytes , macrophages, and T 
lymphocytes, and, because of its aff-inity for hepari n , we n amed it 
heparin-binding-EGF-like growth factor (HB-EGF) (Higashiyama 
ef a/, 1991, 1992; BJotnick ef a/, 1994). HB-EGF is a highly 
glycosylated protein and it potent mitogen for fibroblasts, sl1100th 
muscl e cells (Higashiyama e( fI/, 1991, 1992, 1993), and keratino-
cytes (Marikovsky cl fI/, 1993), but not for endothelial cells, 
H.B-EGF is also the predominant heparin-bindin g growth factor 
mitogenic for Ralb/c mOllse 3T3 fibroblasts that is present in 
wound fluid during the first few days following injury (Marikovsky 
e( tI/ , 1993) . In this scudy, th e growth factors involved in keratino-
cyte prol.iferation during th e re-epitheliali zation in a healing wound 
were examin ed. Most growth factors that stimula te keratinocyte 
proliferation bind h eparin. T h ese include: ac idic and basic fibrobJ asr 
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growth facto r (aFGF, bFGF) (Falco et ai, 1988; Ristow and 
Messmer , 1988; Gospodarowicz et ai, 1990), keratinocyte growth 
factor (KGF) (Rubin ct ai, 1989; Marchese el ai, 1990; Wemer el ai, 
1992), h epatocyte growth factor (HGF) (Kan et ai , 1991; Mat-
sumoto eI ai, J 991; Rubin ct ai, 1991), amphiregulin (Shoyab et ai, 
1989; Cook ct ai, 1991) , and HB-EGF (Marikovsky et ai, 1993). 
Therefore , hepa rin affinity chromatograph y was use d to quantitate 
various hepa rin-bindin g growth f.,ctors in wound Auid that are 
mitogenic for keratinocytes. 
Since the skin of pigs is similar to that of humans, it is a u seful 
model system for studying wound repair. R.ecently we developed a 
method in which liquid-tig ht vinyl c hambe rs that contain n o rmal 
saline are placed over partial thickness excisional wounds made o n 
the back of a pig (Breuing ef ai, 1992; Mat'ikovsky ef ai, 1993). With 
such chambers, wound Auid can be continuously coll ected a nd 
analyzed for g rowth factor activity. 
In tlus report, we present evidence that the predominant h epa rin-
binding growth factor mitoge nic for Balb/MK kerarinocytes and 
present in pig wound Auid during the initial d ays following injury is 
an HB-EGF-like molecule. The mitogeni c activi ty of HB-EGF is 
markedly potentiated by IGF-1. It appears that the levels of 
HB-EGF and IGF- I after injury and the syne rg ism between them 
may be importan t variables in regulating re-epithelialization during 
wo und repair. 
MATERIALS AND METHODS 
Materials Mouse EGF, human IGF-I, human platc let-deri ved growth 
facto r 1313 were purchased from Collaborative Biomedical Prod ucts (Bed-
ford, MA) . Recombinant human keratinocyte growth f:,ctor (KGF) was 
prepared as described previously (Ron r ( ai, 1993). Recombinant human 
hepatocyte growth f.,ctor (HGF) was generated with a baculovirus expres-
sion system and iso lated fi'om insect cell culture Auid by hcparin chroma-
tography (manuscript in preparation). R.ecombinant HB-EGF and neutra l-
izing anti-human HB-EGF polyclonal antibody 197 were kind ly provided 
by Dr. Judi th A. Abraham (Sci os Nova Inc., Mountain View. CAl· Mouse 
monoclonal anti-human KGF ncutralizing antibodies were obtained as 
previously described (Alarid el ai, 1994). R.abbit anti-human HGF neutral-
izing antibodies were obta ined as previously described (Rubin el ai, 199 '1 ). 
Cell Proliferation 13ALB/ MK mouse epidermal kerarinocytes were 
kindly provided by Dr. Stuart Aaronson (National Cancer Ins titl1[c, 13c-
thesda, MD). T he proliferation of Balb /c 3T3 ce lls (Higashiyama c( ai, 
1991), bovine capillary endothel ial cells (Higash.iyama c ( ai, 1991), and 
BaJb/ MK ce ll s (Rubin c ( ai, 1989) was assayed by measuring the incorpo-
ration of [] Hj thymidine in to DNA as previousl), described. DNA synthes is 
assays were performed in triplicates and background was substracted . For 
neutralization experiments neutra lizing anti-HGF (10 J.Lg/ ml) Or anri-KGF 
(5 /-Lg/ ml) antibodies were added directly to cell s in culture. Neutralizing 
anti-HB-EGF polyclonal 'lJltibody 197 was rai sed in goats directed against 
recombinant 77-amino acid human HB-EGF. Two micrograms of antibody 
were added to sa mples for 16 h at 4°C and then added to cclls. T he 
an tibodies arc specific and do not interact with either EGF, TGF-ct, or 
amphiregulin. 
W ound Fluid Preparation Wound Auid was co llected as previously 
described (Breuing el ai, 1992; Marikovsky el III , 1993). BrieAy, medium 
partial thickness excisionaJ wounds (15 X J 5 X l. 2 mm; 1.6-20 wounds per 
pig) were created on the backs of four fe male Yorkshire pigs. Each wound 
was covered witb a separate liquid-tight vinyl chamber filled witb 1.2 ml of 
normal sa line conta ining penicillin (100 U / ml) and streptomycin sul fate 
(100 J.Lg/ml) . Wound Auid from all the wounds was pooled. T he average 
volume of wound Auid collected every 24 h fi'oll1 each wound during tbe 
first 3 days was 2.4 m l. The so lution was exchanged every 24 h, pooled 
druJy, centrifuged, filtered through 0.45-,...,m filte rs, and 6:ozen at - 20°C. 
Wo und Auid was co llected from four difFerent pigs with reproducible 
results. 
Heparin Affinity Fast Protein Liquid Chromatography Wound 
fl uid (20-25 ml) was applied to a heparin-TSK 5PW column (7.5 cm X 8 
nun; TosoHaas Corp., Southboro, MA), using a Pharmacia fast protein 
liquid chro matography system (Pharmacia LlC13 Biotechnology, Uppsala, 
Sweden). Heparin aftinity chromatography was carried out as previously 
described (Marikovsky el ai, 1993). BrieAy, samples wcre eluted w ith a 
linear gradient of 0.2- 2.0 M NaCI in 10 mM Tris-HC I (PH 7.4). Aliquots 
(5-10 J.Ll) of the fractions were assayed for stimulation of DNA synthesis in 
Balb/MK keratinocytes in the presence of insuUn (5 J.Lg / m l). 
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Sodium Dodecyl Sulfate-Polyacrylamide Gel E lectrophoresis So-
dium dodecyl su lf.,te-po lyacrylamide gel electrophoresis and western blot-
ting were carried out as previously dcsc,;bcd (Marikovsky er al. 1993). 
BrieAy, samples were concentra ted on mini-heparin Sepharose columns, 
ana lyzed under reducing conditions by sodium dodecyl sul fate 15% poly-
acrylamide ge l e1ectrophorcsis. and transfcrred to nitrocellulose paper 
(Schleichcr and Schuell , Keene, NH) in 200 mM 3-(cyclohc:\:ylamino)pro-
panesulfonic acid buftcr (pH 11). A rabbit Anti-HB-EGF antiserum was 
raised against the peptide S-S-K-P-Q-A-L-A-K-P-Cys. wh.ich corresponds 
to amino acids 15-24 in the ma ture, 7S-amino acid form of human HB-EGF 
(Higash.iyama et II I. 1991). but with a cyste ine residue added at the C 
terminus. The peptide was synthesized by so lid-phase methods (Mcrrifie ld, 
1963) using an automated Applied Diosystems 430A pep tid e synthesizer 
(Foster C ity, CAl . T he synthetic peptide was conjugated to KLH (Boeringer 
Mannheim, Indianapo lis, IN) according to estab lished methods (Ishikaw .. e( 
ai, 1983). Fem;] le New Zealand Wh.ite rabbits wcre i ,~jected intradermally 
at multiplc dorsa l sites with 0.25 mg of KLH-peptide conjugate emulsified 
in compl ete Freund 's adjuvant and boosted at 4-week interva ls using 
il1 COlllplctc Freund's adjuvant. The antiscrUI11 cross-reacted \:v-ith native and 
recombinant HB-EGF. T his peptide amino acid sequence does not exist in 
human EGF or TGF-ct, and the anti-HB-EGF antiserum did not cross-react 
with either one of these growth f.1ctors. Normal rabbit serum, anti-EGF, 
and anti-TGF-a antibodies did not cross-react with native or recombinant 
HB-EGF. Aftcr exposure to the anti serum. the blot was incubarcd with 
alkaline phosphatase-conjugated anti-rabbit anti bodies (Protoblot system; 
Promega, Madison , WI). 
IGF-I Radioimmunoassay (RIA) Wound Auid from seven diftcrel1t 
pigs was collected daily after injury and extracted by acid e thallol , and IGF-I 
was deren-nined in trip licate by a C0111111crc iaIJ y available radioinll11Ut10assay 
kit (Nichols Institu te Diagnostics, San Juan Capistrano , CAl. 
InsuJin Radioimmunoassay Insulin was determined in wound Auid by 
the competitive RIA assay using ' 2s l_labeled insulin (Heding. 1972). 
All experimcnts are the result of two to th.ree independent experiments. 
RESULTS 
Histological sectio n s of th e wound site revea led that re-epithelial-
ization in this wound m odel was compl ete b y 6 d ays after .irtiury 
(not shown) . We have examin ed the distribution of kerati nocyte 
g rowth factors during this time period . 
Appearance of Heparin-Binding Growth Factor Activity for 
Keratinocytcs in Wound Fluid After Injury Wound Auid 
samples were collected daily for 10 days fi'om partial thickn ess 
excisiona l wounds made on the back of pigs. These samples were 
fi'actionated by heparin affini ty chromatograph y an d analyzed for 
mitogenic activity on BALB/ MK keratinocytes. From 1 to 5 days 
after injury, two broad peaks of growth factor activity were readily 
detec ted: a re lative ly minor peak eluted with 0.5- 0.6 M and a 
major peak eluted with 1.0-1.1 M NaCI (Fig 1). On the first day 
of injury som e mitoge nic activ ity was present also in the .first 
fi'a ction of the elutio n. During days 1 and 2 after injury, the ratios 
of t he h eparin-column-e lu ted g rowth factor activ ities present in the 
major (1 .1 M NaCl) and minor (0.5 M NaCI) peaks were 2: 1 and 
3:1, respectively (Fig 1) . These two peaks of h eparin-binding 
growth facto r ac tivity were maximal at 2-3 days after injury and 
disappeared by day 6 (Fig 1) . T he calculated mitogeluc activity for 
BALB/ MK keratinocytes of the he parin-binding fraction was abou t 
ha lf that o bse rved with the nonfTactionated wound Auid. 
Human macro phages and T lymphocytes secrete HB-EGF, a 
he parin-binding g rowth f.Ktor that is e lute d fi'om a heparin column 
with 1-1.2 M Na C I (Besner cl ai, 1990; Higashiyama et ai, 1991; 
Blotnick ef ai, 1994). T he wound fluid-derived peak ofkeratin oc),te 
growth factor activity that e luted w ith 1.1 M NaCI comigrated with 
mac rophage-derived HB-EGF and was mitogenic for 3T3 fibro-
blasts. but not for bovine ca pillary e ndothelial cells (not shown). 
T hese are properties of HB-EGF, but not of aFGF, bFGF, KGF, 
ampluregulin (AR) , and HGF. Moreover, neutralizing antibodies 
specific to KGF and HGF did not affect the mitogenic activ ity 
e lu ted with 1.1 M NaCI (Table I) . Whether these antibodies 
cross-react with porcine reagents in unknown. Takcn together it 
was plausible that the mitogenic activity e lu ted w ith 1.1 M NaCI 
might be HB-EGF-like . A ccordingly, the 1.1 M NaCI peaks 
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Figure 1. Heparin affinity column analysis of pig wound fluid . 
W o und Auid was collected dai ly afte r injury (20 ml) and applied to 
heparin-TSK aflini ty co lumns. Fractio ns were elu ted w ith a 0.2- 2 M NaCI 
gradient in 10 mM Tris-H CI (pH. 7.4). Aliquots (5-1 0 I.d ) of th e fractions 
were assayed fo r their abiLity to stimulate DNA synthesis in l3ALB/MK ce ll s 
by measuring the incorporation of [J Hlrhyrnidil1c into DNA as prev io usly 
described . DNA synthesis assays were perfo rmed in tripli cates and back-
ground was substracted. These results were reproducible in wound Au id 
samples obtained from fo ur separate pigs. 
o btained at days 1-5 postinjuTY w ere an aJyzed by immunoblotting 
usin g anti- HB-EGF antibodies pl'cpared against a peptide corre-
sponding to an amino- terminal region of human l-ID-EGF. T hese 
an tibodies specifi cally cross-reacted with 18 - 20 kDa of native 
hum an HB-EGF derived fi'om U-937 cells (Higashiyama et nl, 
1991) , (Fig 2, I.nll c 1) and with bacte rial-derived recombinant 
hum an HB-EGF (Fig 2, Inlle 7), but not with human EGF o r human 
TGF-O' (not shown) . T he anti-HB-EGF antibodies cross-reacted 
with a 12-14-kDa species in wound fluid (Fig 2, lalles 2- 6) th at 
comigrated with the nonglycosylated 12- 14-kDa recombin ant 
HB-EGF (lalle 7). T h e highest lev els of HB-EGF in the porcine 
wound fluid were o bserved 2-3 days follOWing injury and de-
creased thereafter. Wo und fluid-deri ved HB-EGF has a lower 
molecular weight form compared to native HB-EGF deri ved from 
U-937 cells, possibly as a result of being processed by proteases or 
glycosidases (Marikovsky ct "I, 1993). 
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Figure 2 . Detection of HD-EGF level in wound fluid by western 
blot a nalysis . Wound Auid samples from days 1-6 were collec ted daily 
(about 20 m1) and app lied to heparin-TSK affin ity columns. T he mitogenic 
activity e lu ted w ith 1.1 M N nel was concentra ted on hcparin-Sepharose 
mini-columns and analyzed by sodium dodecyl sulfate 15% po lyacrylamide 
gel elec trop ho res is. Proteins were transferred to ni trocell ulose paper in 200 
mM 3-(cyclo h exylamino)propanesu lfon ic acid butle r (pH 11) and incubated 
with anti-HB-£GF antise rum as described in Materials alld Meth"ds. Lnllc 1, 
purifie d native human HB-EGP (100 ng); ImIL's 2-6, wound Auid collected 
on days 1-5 after inj ury, respectively; lalle 7, recombinant HB-EGF (30 ng) . 
Levels o.f IGF-I in Wound F luid IGF-I levels, as de termined 
by RIA, were 22 ng/m l in wound fluid on the first day fo llowing 
injury, reached a maximum (44 ng/ml) at 2-3 days after il~ury, and 
decreased rapidly thereafter (Fig 3) . IG F-I levels by da ys 4 -5 were 
6-8 ng/ ml and were not de tectable 6 or more days after injury (Fig 
3) . The actual IGF-I levels are probnbly twice as high, because 
wo un d Auid is di luted by sa line in the wound flu id chambers. 
Synergism between HB-EGF and IGF-I T he tim e course of 
IGF-T levels in wound Auid followin g injury was closely parallel to 
that of n onf rac tionated wound Auid mitogenic activ ity , suggesting 
a possible intenlctiv e role for JGF-I and wound fluid-d erived 
growth factors (Fig 3). IGF-I by itself had a very wea k mitogenic 
e ffect 011 BALB/MK keratin ocytes at th e concentrations found ill 
wound fluid (Fig 4A) . On the othe r hand , the mitogenic activity of 
wo und fl uid-de rived HB-EG F from days 2- 3 was greatl y increased 
at ph ysiologica l concentrations of l GF-I (20-100 ng/ml). At 100 
ng/ml IGF-I th e synergy with wound fluid- de rived HB-EGF 
activity was about 50- to 60-fo ld (Fig 4B) . T he syne rgis tic activi ty 
of IGF-J w as determined more precisely using a knowll amount of 
purifie d native HB-EGF and JGF-l in the wound Auid physiological 
ran ge (Fig 5) . Native HB-EGF was mitogenic for BALB / MK cells 
in a dose-dependent manner rangilJg from 1 to 10 ng/ ml (Fig SA). 
T he mitogenic activity of HB -EG F at 1 ng/ ml was minim al but was 
rn arkedly increased by IGF- l in a dose-dependent manlle r up to 40-
to 50-fold , with a half-maxima l increase occurring at about 40 
ng/ml JGF-l (Fig SB). 
To examin e whether JGF-l is biologically active and is not 
inactiva ted by IGF- l binding protein-like molecules in wound flui d, 
IGF-[ was added to wound fluid and its effect 011 wound flu id 
mitogeniCity fo r BALB/MK was determined. IGF-l (20 -100 ng/ 
Table I. Neutralizing Anti- KGF and Anti-HGF Ab Do Not Effect the Mitogenic Actjvity of Wound 
Fluid-Derived HB- EGF 
Growth l~ a ctoTs 
N o ne 
KGF (10 ng/ml) 
H GF (10 ng/ml) 
W o und fluid ]-IJ3-EG F 
DNA Synthesis (cpm X 10- ' ) 
2.9 ::+:: 0.6" 
254.2 :t 9 .7 
67.6 :t 0.6 
177 .4 :t 7.0 
+Anti-KGF Ab (cpm X 10- .1) 
2.9 ::+:: 0.6 
29 ::+:: 2.5 
58 ::+:: 10.5 
178.8 ::+:: 0.8 
+ Anti-HGF Ab (cpm X 10- -') 
2.9 ::+:: 0.6 
250.5 ::+:: 5. 0 
6.2 ::+:: 0.3 
182. 5 ::+:: 13 
(( GF, H GI:: , and wo un d Huid-dc l"ivcd peak eluted w ith t . 1 M N<lCI (collected O il dnys 1-2 postinjury) \l\' l:! rc ana lyze d (o r th eir abiliry to scilllubc-c DNA syn the ... i .. hy I11 C.1S urillg 
the incorporotio n of I' H]th ymidil1e into DNA in 13ALll/ MK kc ratinocytcs in th e presence or insulin (5 f.l-g/ ml) ;\n d in the presence of n~utr;\1i2ing ;l\\ti-KG F ;l\\d anti-H GF Ab. 
DNA synthesis nssays \NCre pc rformeci in triplic:l tcs :lI1d hackgro und was substractcd . Wound fl uid-deri ved l-l13- EGF rcprcsclI (.s 1. 1111 of o rigirwI wOl/ lld ffuid . 
II Mean :t: SD. 
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Figure 3. IGF-I levels correlate with the mitogenic activity of 
unfractionated wound fluid for BALB/MK keratinocytes. Wound 
fluid from seven different pigs was collccted da ily after injury and extracted 
by acid ethanol, and IGF-l was determilled in t.-ip licaces b), a commercially 
available radioimmunoassay kit. T he IGF-I level of a representative exper-
iment is shown (01'1'11 sq llares). NonfractiOllated wound fluid (30 ILl), 
collected dail y, was ana lyzed for the ability to stimulate DNA sYllthesis in 
BALB/ MK kerntinocytes by measuring the incorporation of ["H]thYl11idine 
into DNA (closed circles). DNA synthes is assays were performed in triplicates 
and background was substracted. 
m l) in creased, in a dose-dependent mann er, the a lready high 
mi togenicity for BALB/MK kel'atinocytes of wound fluid . T h e 
increase was 5-fold for day 1, 2-fo ld for d ay 2, 3-fold for day 3, and 
20- fold for d ay 4 after injury (Fig 6). T he re lati ve ly hig h e r d egree 
of syn ergism of exogenous IGF- 1. for day 4 wound fluid probably 
re fl ects the re latively low amount of endogenous IGF-I prese nt by 
that time as was shown in Fig 3 . 
Insulin at a concentration 100-fold higher than that oflGF-f (1-5 
J.Lg/mJ) a lso syn e rg ized HB-EGF mitogenicity fo r BALB/MK cells. 
The le ve ls of insulin in wound fluid, however, as dete rmined by 
compe titi ve RIA , w e re less than 2 ng/ml (not sh o wn) . 
DIS C USSION 
Re- epith elialization is essential for wound healing. K era tinocytes, 
the m ain cell type in the epidermis, mig rate into w o und s and 
prolife rate soon after injury. Growth factors that induce ke "a tin o-
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Figure 4_ Synergism between IGF-I and wound fluid-derived HB-
EGF~ .1 GF-I at va ri o lls 311101lllts was ana lyzed for th e ability to stil1uda tc 
DNA synthes is in BALB/ MK keratinocytes by measuring the incorpo ration 
of eH]thymidinc into DNA as previousl )' described. DNA synthes is "5says 
were performed in t.-iplicates and background was substracted. DNA 
synthesis without (A) or with (8) wound fluid-deri ved HB-EGF (represent-
ing 1 1111 of original wound fluid). Em1/' bars, lII eall j: SD. 
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Figure 5. Synergism b e tween IGF-I and native HB-EGF. Pu.-i fied 
human native H13-EGF was analyzed for dIe abi lity to stimulate DNA 
synthes is in J3ALB/ MK kera tinocytes by measuring the incorporation of 
l' H] thymidine into DNA as previous ly desc,ibed. DNA syndlesi5 assays 
wcre pcrfonncd in triplicates and background was subsu·acted. T he efFec t O il 
DNA synthesis was examined by HJ3-EGF alone (A), and by HU-£GF 
(1 ng/ml) in tbe presence of va rious amounts of IGF-I (B). Error bars, 
lIl enn ± SD. 
cyte proliferatio n and migratio n includ e EGF (Rheinwald and 
Green, 1977; Maciag et ai, 198 1; Tsao ef ai , 1982), TG F-a, an 
epithe lia l cell mitogen (B alTand on and G reen, 1987; Coffey CI aI, 
1987) , several h eparin- binding growth Glctors such as bFGF o r 
" FGF (Falco el ai, 1988; Ristow and M essm er , 1988; Gospodarow-
icz ct ai, 1990) , KGF (Rubin ci ai, 1989; Marchese et ai, 1990), HGF 
(Kan et ai, 1991), amphiregulin (Shoyab ct ai, 1989; Cook ct ai, 
1991 a), and HB-EGF (Mal;kovsJ...-y el ai, 1993) . T herefo re, wound 
fluid was analyzed fo r biologica lly active he parin-binding growth 
f;Jctors to elu cida te the id entity and quanti ty of active h eparin-
bindin g mig ratio n and proliferation stimulatory facto rs that parti c-
ipate in re- epithelializa tio n during wound repair. T h e m;u o r h epa-
rin-binding growth f.'lctor fo r kc ratinocytes in pig wound fluid , in 
th e first week followin g .injury, is HB-EGF. T h e appearan ce o f 
HB-EGF in w o und fluid may be an early response to injury. 
HB-EGF appears within 24 h of the injury, is m aximal by 2- 3 days 
late r, and is no longer detecta ble 6 days postinjury, when re-
epith e lializa tion is comple te and wounds a re m acroscopica lly 
h ealed. 
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Figure 6. IGF-I stil11ulates the mitogenic activi ty of wound fluid 
for BALB/MK keratinocytcs. IGF-I at variolls concentrations was ana-
lyzed for the abiLi tv to stimula te DNA synthesis in BALB/ MK keratinocytcs 
in the presence of nonfi'actionated w~und f1llid co llected 1-4 days aftc r 
injury . Day 1 (ope" sq" ares), day 2 (ope" circles), day 3 (dosed sq" ares) , day 4 
(opell Iria ll,~/es) . DNA synthesis was measured by the incorporation of 
['H]thymidine into DNA as previously described. DNA synthesis assays 
were performed in trip li cates and background was Sllbstractcd. Em". 1101'S, 
menn :!: SD. 
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Table II. Neutralizing Anti-HB-EGF Antibodies 
Decrease the Mitogenic Activity ofWoul1d 
Fluid-Derived HB-EGF 
G rowth Factors 
H13-EGF (1 ng/ ml) 
W.F. da y 2 
W .F. day 3 
DNA Syn thesis (Cplll) 
6300 ::t 300" 
7200 ::t 700 
9400 ::t 900 
+ Anti-HB-EGF At> (Cplll) 
200 ::t 100 
2900 ± 500 
5100 ::':: SOD 
NClIU';lliz ing nnti -HU-EGF antibodies were ex amined for their cfl:cct 0 11 the 
micogcni c activity o f \,vOUlld Auid. Aliquots (7 .5 pJ) of wound nuid (w .r .) derived 2- 3 
da ys postinjury Or rctOfnbinanc HU-EGf were incubated in presence of tl CI.l tra Jj z in g 
anti - I-IB-EG F-spccifi c Ab at 4°C for 16 h. DNA syllthc si ~ was c,\:jllnin cd by ll1Casuring 
rhe in corpo ration o f rJH]rh Yll1idinc inro DNA in BALI3/MK kcrarinocyt...: s. DNA 
synthesis assays were performed in triplicates. and background was suhstracrcd. 
" M ean ::t: SO. 
The evidence that the major heparin-blnding growth factor for 
keratinocytes, found in wound fluid is HB-EGP-like is that: i) it is 
eluted from TSK heparin columns with 1.1 M NaCl, as does native 
and recombinant HB-EGF, ii) it is mitogenic for 3T3 fibroblasts and 
keratinocytes, but not for endothe lia.1 celis, iii) it cross-reacts 
specifically on a western blot with antibodies that recognize an 
amino-terminal region of l-D3-EGF, iv) it binds to EGF-receptor 
and indu ces EGF-receptor phosphorylation (Marikovsky et ai, 
1993). The mitogenic activity for ker<ltinocytes of th e heparin-
binding fraction in wound fltlid accounts for about 500/0 of the 
mi togenic activity of nonfractionated wound fluid. HB-EGP is the 
most prominent heparin-binding nutogen for keratinocytes in 
wound fluid. Indeed, ne utralizing anti-I-D3-EGF-specific antibodies 
lnhibited about 50% of the mitogenic activity for BALB/MK 
keratinocytes of nonfractionated wound fluid from days 2 to 3 after 
injury (Table n). T he nonheparin binding growth factor activity 
could be EGF, TGF-a, or some other growth factor. During th e 
first 3 days following injury, the es timated concentration of HB-
EGF if) wound fluid as calculated from its mitogenic activity for 
BALB/MK is 0.4-1 ng/ml. 
Heparll1-binding growtb factors other than HB-EGF, may also be 
present in the wound fluid-d er1ved 1.1 M NaCl peak of activity. It 
is unlikely that A.R, a heparin-bindi.ng member of the EGF family 
(Shoyab el ai, 1989) is present ill this peak, however, beca use the 
mitogenic activity of native human HB-EGF and of the wound 
fluid-d erived HB-EGF-like activity for keratinocytes are potenti-
ated by heparin (Marikovsky el ai , 1993), while AR is completely 
inhibited by heparin (Cook et ~I , 1991; Marikovsky and Klagsbrun, 
unpublished results). It is also not likely that HGF or FGFs are 
present in this peak, beca use it was not mitogenic for endothelial 
cells. 
In culture, HB-EGF is produced by human peripheral 1110no-
\ cytes, m3 crophages, and T lymphocytes (Besner c/ ai, 1990; Blot-
' nick el nl, 1994) as well as by keratinocytes (Barnard et ai, 1994 ; 
kash.imoto et ai, 1994). The time course of the appearance of 
~-EGF in wound Auid parallels that of ll1onocyteslmacrophages 
and T lymphocytes at the wound site . Macrophages and T lym-
phocytes accul11u late at the wound site within 24 h after injury and 
reach max imal levels 3 days after injury, and their levels decrease 
immediately afterwards (Leibovi ch and Ross, 1975). T lympho-
cytes, which secrete I-IB-EGF (Blotnick et ai, 1994) accumulate too 
at the site of injury within 24 h . Pig skin keratinocytes harvested 
fi·ol11 a w6 und and grown in culture ex press HB-EGF mRNA 
(Marikovsky and KJagsbnm, unpublished results) . Sl1100th muscle 
and endothe1.ial cells also express HB-EGF mRNA (Yoshizumi el 
nl, 1992; Dluz 1el aI, 1993). Whether the HB-EGF in wound fluid 
originates from Inacrophages , T lymphocytes, keratinocytes, or 
other types of ce ll~ is not clear. 
Pig wound fluid 'contains another heparin-bi.nding activity eluted 
at 0.5 M NaCI th ~\ is less abundant than HB-EGF in terms of 
activity. Platelet-den ,\ed growth factor, which is present in pig 
wound fluid (Marikovs~y el ai, 1993) and elutes at 0.5 M NaCl, is 
not mitogenlc for BALB/MK cells. In addition, neutralizing anti-
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bodies specific to platelet-derived growth factor did not affect the 
mitogenic a ctivity elu ted with 0.5 M NaCI. It is unlikely that tlus 
activity represents KGF or HGF, which are mitogens for keratino-
cytes and are eluted fr0111 heparin column with 0.6-0.8 M NaCI 
(Rubin el ai, 1989; Marchese er ai, 1990; Kan el ai, 1991). In 
addition, ne utralizing antibodies speciiic to KGF and HGF did not 
effect th e mitogenic activity eluted with 0.5 M NaCI nor that elnted 
with 1.1 M NaCl. The factor responsible for the mitogenic activity 
for keratinocytes e luted with 0.5 M NaCI from ill1ll1obllized 
hep!lrin could be novel and remains to be identifi ed. 
Pig wound fluid also contains IGF-1. IGF-l is not mi togenic for 
BALB/MK keratinocytes. At wound fluid physiological concentra-
tions (40-100 ng/ ml), however , lGF-1 markedly increases the 
mitogenic a ctivity of wound fluid-derived HB-EGF for BALB/MK 
keratinocytes as well as that of native HB-EGF. Interestingly, IGF-I 
synergizes also with the heparin binding activity elu ted with 0.5 M 
NaC I. At lugh concentrations (1-5 fLg/ml), insulin also increases 
the mitogeni city of HB-EGP for BALB/MK keratinocytes. It is 
generally accepted that at high concentrations. in sulin acts through 
the IGP-l receptor (Flier ci aI, 1986); bowever, the levels of insulin 
in wound fluid are less than 2 ng/m l, a concentration at which 
insulin has no synergistic effect. The source of IGF-I in the wOIU1d 
is not known, but the initial surge of IGF-I after injury is undoubt-
edly aided by lysis of platel et a -granules (Karey and Sirbasku, 
J 989) . Other cells that may produce IGF-I in the wound are 
Illacmphages OenJlische et aI, 1987; Rappolee cf Ill, 1988) and 
fibroblasts (Spencer el ai, 1988). 
IGF-llevels parallel HB-EGF le vels and mitogenic time course in 
wound fluid . Both f.1cto rs reach maximulll 2-3 days after injury, 
decrease rapidly thereafter, and disappear by 6-7 days followin g 
injury . Similarly, the mitogenic activity of nonfractionated wound 
fluid for BALB/MK keratinocytes follows the same kinetics. At its 
physiological co ncentration in wound fluid (0.4-1 ng/ ml), I-I.B-
EGF alone h as a low mitogenic effect On keratillOcytes; however, it 
synergizes strongly with IGF-I (20 -1 00 ng/ ml). T his suggests that 
part of the high m.itogeni c activity in the wound site at the fiJ"St 3 
days fo llowing injury, during which HB-EGF levels are 0.4 - 1 
ng/ml and IGF-I concentration is 40-1.00 ng/ml, may be attributed 
to the synergism between IGF-I and HB- EG f . At day 4 after llljury, 
there is substantial HB-EGF protein, but the mitogenic activity of 
wound fluid as well as JGF-I leveh (6 ng/ml) are low, suggesting 
that the low activity is due to lack of synergizing IGF-I levels. At 
day 6 both factors as well as the mitogenic activity of wound fluid 
disappear. [nterestingly, re- epithelialization in this wound model 
was completed within 6 days after injury. Because IGF-I greatly 
increases tbe mitogenic activity of HB-EGF and beca use their 
appearance in wound fluid has the same kinetics as th at of the 
re-epitheli<lliza tion process, we suggest that th ey may be importan t 
variables fOJ" regulating re-epithelialization during wound repair. 
lnsll lin /lGF-1 is the only factor absolutely required to support 
ke ratulocyte proliferation. BALB/MK cells were shown to depend 
exquisitely on two complementary growth factors: illsulin/ lGF-I 
and either EGF, <lcidic and basic FGF, or KGF (Falco el ai, 1988; 
Rubll1 ct al 1989). 
Various growth fa ctors are present in wound fluid during repair. 
We suggest that the activity of a growth f;lctor In modulating 
wound rep,Lir can lIot be evaluated merely from its contribution by 
its own cell migration or proliferation , and it might be more than 
the StUll of all growth factor activities . Our studies indicate instead 
that complex interactions occur in wound fluid in which growth 
fa ctors modulate the activity of other growth factors. 
This '/lorl< WaS SlIj'j)(J}·red by N nri011C11 IlISrilllres "f Healll, Crnllls CA 37392 "lid 
GM 47397 (to M. K.). 
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